Sleep for attention by attention to sleep
- Conditions
- ADHD in adultsSleep disorders
- Registration Number
- NL-OMON20912
- Lead Sponsor
- PsyQ Expertise Center Adult ADHD, The Hague.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 60
In order to be eligible to participate in this study, a subject must meet all of the following criteria: age 18-50 years, diagnosed ADHD (or ADD), understanding of the Dutch language, a positive screening on the HSDQ for at least one of the following sleep disorders: DSPS, RLS / PLMS, sleep-disordered breathing, and/or insomnia.
A potential subject who meets any of the following criteria will be excluded from participation in this study: comorbid disorders that require immediate treatment, psychotic disorder, mental retardation, pregnancy or active wish to conceive (in females), use of ADHD or sleep medication in the prior month, history of sleep treatment, and any morbidity affecting sleep (e.g. diabetes).
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The comparison of the reduction on the ADHD-RS between treatment arms
- Secondary Outcome Measures
Name Time Method The comparison of the reduction on the objective ADHD symptoms using the QbTest, and the depressive symptoms using the QIDS between treatment arms.<br><br>The study will also provide the opportunity to examine the following: <br>a. The baseline EEG characteristics and the hypnograms of the total group of adults with ADHD. <br>b. The evaluation of each treatment arm on the improvement of subjective sleep quality using the PSQI, and also objective sleep using the Actiwatch and home-PSG characteristics (EEG and hypnogram). <br>c. The types and severities of sleep disorders and their indicated treatments in adults with ADHD. <br>d. The effect of TAU on the objective sleep parameters from the Actiwatch and home-PSG
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.